Cardiff Oncology, Inc. (FRA:XE7C)

Cardiff Oncology Revenue

Cardiff Oncology had revenue of $120.00K USD in the quarter ending September 30, 2025, a decrease of -27.27%. This brings the company's revenue in the last twelve months to $501.00K, down -27.29% year-over-year. In the year 2024, Cardiff Oncology had annual revenue of $683.00K with 39.96% growth.

• Revenue (ttm): $501.00K
• Revenue Growth: -27.29%
• P/S Ratio: 232.37
• Revenue / Employee: $15.18K
• Employees: 33
• Market Cap: 99.22M EUR

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	683.00K	195.00K	39.96%
Dec 31, 2023	488.00K	102.00K	26.42%
Dec 31, 2022	386.00K	27.00K	7.52%
Dec 31, 2021	359.00K	-7.00K	-1.91%
Dec 31, 2020	366.00K	121.37K	49.61%
Dec 31, 2019	244.63K	-133.69K	-35.34%
Dec 31, 2018	378.33K	-127.08K	-25.14%
Dec 31, 2017	505.40K	124.33K	32.63%
Dec 31, 2016	381.07K	68.26K	21.82%
Dec 31, 2015	312.81K	32.63K	11.65%
Dec 31, 2014	280.18K	20.93K	8.07%
Dec 31, 2013	259.25K	-191.16K	-42.44%
Dec 31, 2012	450.40K	192.71K	74.78%
Dec 31, 2011	257.70K	-273.63K	-51.50%
Dec 31, 2010	531.33K	-	-